Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,357,157
-$861,631 QoQ
Shares Held
58,233
-1.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.29%
of 13F equity value
Holder Rank
#496
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calydon Capital holds $35,751,780 across 10 Drug Manufacturers - General names. GILD ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,979 | $9,391,556 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
58,233 | $7,357,157 | |
| 3 | AMGN |
Amgen Inc
|
20,308 | $7,353,932 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
123,497 | $7,115,897 | |
| 5 | LLY |
ELI LILLY & Co
|
1,509 | $1,809,940 | |
| 6 | AZN |
Astrazeneca PLC
|
4,923 | $933,499 | |
| 7 | NVS |
Novartis AG
|
5,755 | $901,923 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,772 | $356,202 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,357,157 | 58,233 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,218,788 | 58,971 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,964,598 | 64,890 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,337,877 | 66,107 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,185,579 | 82,850 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,606,896 | 76,813 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,075,634 | 76,601 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $6,371,169 | 75,992 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,718,428 | 97,922 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,440,066 | 87,919 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,962,753 | 61,261 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $4,637,437 | 61,882 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $4,840,997 | 62,813 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $5,336,215 | 64,315 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,518,676 | 75,931 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $323,378 | 5,242 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $302,065 | 4,887 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $289,521 | 4,870 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $432,828 | 5,961 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $397,725 | 5,694 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $378,936 | 5,503 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $760,759 | 11,771 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $258,208 | 4,432 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,402,402 | 53,844 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,436,909 | 44,670 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,244,947 | 56,781 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||